Synopsis of recent research by authors named "Anna Acquadro"
- Anna Acquadro's research primarily focuses on the interactions between targeted cancer therapies and immune modulation, particularly in the context of MET-amplified tumors.
- In her 2019 study published in the British Journal of Cancer, she examined the effects of MET inhibition on the interferon-gamma (IFNγ)-induced expression of PD-1 ligands, highlighting the potential for this therapy to influence tumor immune evasion strategies.
- The findings suggest that targeting the MET pathway may enhance the therapeutic efficacy of immune interventions in patients with MET amplification, indicating a need for further exploration of combined treatment approaches.
